Skip to main content
SpringerLink
Log in
Book cover

Natural Products for Cancer Chemoprevention pp 561–575Cite as

The Use of Anti-Inflammatory Agents for Cancer Chemoprevention

  • Chapter
  • First Online:

  • 507 Accesses

Abstract

Over 150 years have passed since the link between inflammation and cancer was first hypothesized, and this relationship is now widely accepted. Inflammation has been described as an important player in all stages in the process of carcinogenesis, and anti-inflammatory drugs have consistently demonstrated cancer chemopreventive activity in various animal models. Considering the global cancer burden and the difficulty to treat most cancers, the development of such a preventive strategy using readily available anti-inflammatory drugs is highly appealing. However, most existing anti-inflammatory drugs come with serious side effects (gastrointestinal bleeding for NSAIDs, cardiotoxicity for COX-2 inhibitors) that would hamper their long-term use in large populations at risk of cancer development. In this context, important efforts have been made by both academia and industry to discover new potent and safe anti-inflammatory compounds with cancer chemopreventive properties. Natural reservoirs are of high interest in support of this prospect, owing to their richness and the chemical diversity they offer. The present chapter recapitulates the main preclinical and clinical advances on the search for anti-inflammatory cancer chemopreventive compounds.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aggarwal BB (2004) Nuclear factor-κB: the enemy within. Cancer Cell 6:203–208

    Article  CAS  PubMed  Google Scholar 

  • Aggarwal BB, Sung B (2011) NF-κB in cancer: a matter of life and death. Cancer Discov 1:469–471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aggarwal BB, Bhardwaj A, Aggarwal RS et al (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783–2840

    CAS  PubMed  Google Scholar 

  • Barnes PJ, Karin M (1997) Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071

    Article  CAS  PubMed  Google Scholar 

  • Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 12:715–723

    Article  CAS  PubMed  Google Scholar 

  • Berge G, Øvrebø S, Eilertsen E et al (2004) Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene. Br J Cancer 91:1380–1383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bettuzzi S, Brausi M, Rizzi F et al (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66:1234–1240

    Article  CAS  PubMed  Google Scholar 

  • Bishayee A (2009) Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2:409–418

    Article  CAS  Google Scholar 

  • Brinkhuizen T, Frencken KJA, Nelemans PJ et al (2016) The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): a phase II, randomized controlled trial. J Am Acad Dermatol 75:126–134

    Article  CAS  PubMed  Google Scholar 

  • Cipolla BG, Mandron E, Lefort JM et al (2015) Effect of sulforaphane in men with biochemical recurrence after radical prostatectomy. Cancer Prev Res 8:712–719

    Article  CAS  Google Scholar 

  • Clamon G (2015) Chemoprevention and screening for lung cancer: changing our focus to former smokers. Clin Lung Cancer 16:1–5

    Article  PubMed  Google Scholar 

  • Cruz-Correa M, Hylind LM, Marrero JH et al (2018) Efficacy and safety of curcumin in treatment of intestinal adenomas in patients with familial adenomatous polyposis. Gastroenterology 155:668–673

    Article  CAS  PubMed  Google Scholar 

  • Curry EA, Murry DJ, Yoder C et al (2004) Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Investig New Drugs 22:299–305

    Article  CAS  Google Scholar 

  • Cuzick J (2017) Preventive therapy for cancer. Lancet Oncol 18:e472–e482

    Article  PubMed  Google Scholar 

  • Dannenberg AJ, Altorki NK, Boyle JO et al (2001) Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2:544–551

    Article  CAS  PubMed  Google Scholar 

  • Deeken JF, Wang H, Hartley M et al (2018) A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies. Cancer Chemother Pharmacol 81:587–596

    Article  CAS  PubMed  Google Scholar 

  • Dhillon N, Aggarwal BB, Newman RA et al (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14:4491–4499

    Article  CAS  PubMed  Google Scholar 

  • Dostal AM, Samavat H, Bedell S et al (2015) The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial. Food Chem Toxicol 83:26–35

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Elshaer M, Chen Y, Wang XJ, Tang X (2018) Resveratrol: an overview of its anti-cancer mechanisms. Life Sci 207:340–349

    Article  CAS  PubMed  Google Scholar 

  • Ghantous A, Gali-Muhtasib H, Vuorela H et al (2010) What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today 15:668–678

    Article  CAS  PubMed  Google Scholar 

  • Ghantous A, Sinjab A, Herceg Z, Darwiche N (2013) Parthenolide: from plant shoots to cancer roots. Drug Discov Today 18:894–905

    Article  CAS  PubMed  Google Scholar 

  • Gravitz L (2011) Chemoprevention: first line of defence. Nature 471:S5–S7

    Article  CAS  PubMed  Google Scholar 

  • Greenberg AK, Hu J, Basu S et al (2002) Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Respir Cell Mol Biol 27:320–328

    Article  CAS  PubMed  Google Scholar 

  • Greenberg AK, Tsay J-C, Tchou-Wong K-M et al (2013) Chemoprevention of lung cancer: prospects and disappointments in human clinical trials. Cancers 5:131–148

    Article  PubMed  PubMed Central  Google Scholar 

  • Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gründemann C, Huber R (2018) Chemoprevention with isothiocyanates – from bench to bedside. Cancer Lett 414:26–33

    Article  PubMed  CAS  Google Scholar 

  • Guo Y, Zhi F, Chen P et al (2017) Green tea and the risk of prostate cancer. Medicine 96:e6426

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hecht SS, Kenney PM, Wang M et al (1999) Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in a/J mice. Cancer Lett 137:123–130

    Article  CAS  PubMed  Google Scholar 

  • Henney JE (2000) Celecoxib indicated for FAP. JAMA 283:1131–1131

    Article  CAS  PubMed  Google Scholar 

  • Ho WE, Peh HY, Chan TK, Wong WSF (2014) Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther 142:126–139

    Article  CAS  PubMed  Google Scholar 

  • Jang M, Cai L, Udeani GO et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220

    Article  CAS  PubMed  Google Scholar 

  • Jansen FH, Adoubi I, Comoe JCK et al (2011) First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Res 31:4417–4422

    CAS  PubMed  Google Scholar 

  • Jiang Z, Chen K, Cheng L et al (2017) Resveratrol and cancer treatment: updates. Ann N Y Acad Sci 1403:59–69

    Article  CAS  PubMed  Google Scholar 

  • Karin M, Yamamoto Y, Wang QM (2004) The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 3:17–26

    Article  CAS  PubMed  Google Scholar 

  • Kumar NB, Pow-Sang J, Egan KM et al (2015) Randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention. Cancer Prev Res 8:879–887

    Article  CAS  Google Scholar 

  • Kumar NB, Pow-Sang J, Spiess PE et al (2016) Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins. Oncotarget 7:70794–70802

    PubMed  PubMed Central  Google Scholar 

  • Kurus M, Firat Y, Cetin A et al (2009) The effect of resveratrol in tracheal tissue of rats exposed to cigarette smoke. Inhal Toxicol 21:979–984

    Article  CAS  PubMed  Google Scholar 

  • Lawrence T (2009) The nuclear factor NF-κB pathway in inflammation. Cold Spring Harb Perspect Biol 1:a001651

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Li ZG, Hong T, Shimada Y et al (2002) Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23:1531–1536

    Article  CAS  PubMed  Google Scholar 

  • Lin K-T, Wang L-H (2016) New dimension of glucocorticoids in cancer treatment. Steroids 111:84–88

    Article  CAS  PubMed  Google Scholar 

  • Liu S-F, Kuo H-C, Lin M-C et al (2017) Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. Oncotarget 8:29711–29721

    PubMed  PubMed Central  Google Scholar 

  • Mao JT, Roth MD, Fishbein MC et al (2011) Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res 4:984–993

    Article  CAS  Google Scholar 

  • McNeil JJ, Woods RL, Nelson MR et al (2018) Effect of aspirin on disability-free survival in the healthy elderly. New Engl J Med 379:1499–1508

    Article  CAS  PubMed  Google Scholar 

  • Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428–435

    Article  CAS  PubMed  Google Scholar 

  • Meylan E, Dooley AL, Feldser DM et al (2009) Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma. Nature 462:104–107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Monteillier A, Voisin A, Furrer P et al (2018) Intranasal administration of resveratrol successfully prevents lung cancer in A/J mice. Sci Rep 8:14257

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nam N-H (2006) Naturally occurring NF-κB inhibitors. Mini Rev Med Chem 6:945–951

    Article  CAS  PubMed  Google Scholar 

  • Nelson CG (2011) Diclofenac gel in the treatment of actinic keratoses. Ther Clin Risk Manag 7:207–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oshima M, Dinchuk JE, Kargman SL et al (1996) Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803–809

    Article  CAS  PubMed  Google Scholar 

  • Pavan AR, Silva GD, Jornada DH et al (2016) Unraveling the anticancer effect of curcumin and resveratrol. Nutrients 8:628

    Article  PubMed Central  CAS  Google Scholar 

  • Pezzuto JM (2019) Resveratrol: twenty years of growth, development and controversy. Biomol Ther 27:1–14

    Article  Google Scholar 

  • Rabadi LA, Bergan R (2016) A way forward for cancer chemoprevention: think local. Cancer Prev Res 10:14–35

    Article  Google Scholar 

  • Ramasamy K, Dwyer-Nield LD, Serkova NJ et al (2011) Silibinin prevents lung tumorigenesis in wild-type but not in iNOS−/− mice: potential of real-time micro-CT in lung cancer chemoprevention studies. Clin Cancer Res 17:753–761

    Article  CAS  PubMed  Google Scholar 

  • Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med 353:1711–1723

    Article  CAS  PubMed  Google Scholar 

  • Samavat H, Ursin G, Emory TH et al (2017) A randomized controlled trial of green tea extract supplementation and mammographic density in postmenopausal women at increased risk of breast cancer. Cancer Prev Res 10:710–718

    Article  CAS  Google Scholar 

  • Saud SM, Li W, Morris NL et al (2014) Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression. Carcinogenesis 35:2778–2786

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705–716

    Article  CAS  PubMed  Google Scholar 

  • Sengottuvelan M, Nalini N (2006) Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br J Nutr 96:145–153

    Article  CAS  PubMed  Google Scholar 

  • Shen B (2015) A new golden age of natural products drug discovery. Cell 163:1297–1300

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takahashi H, Ogata H, Nishigaki R et al (2010) Tobacco smoke promotes lung tumorigenesis by triggering IKKβ and JNK1 dependent inflammation. Cancer Cell 17:89–97

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang X, Liu D, Shishodia S et al (2006) Nuclear factor-κB (NF-κB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 107:2637–2646

    Article  CAS  PubMed  Google Scholar 

  • The United States Preventive Services Task Force (2018) Task force releases recommendations on aspirin to prevent colon cancer, heart disease. https://www.cancer.org/latest-news/task-force-releases-recommendations-on-aspirin-to-prevent-colon-cancer-heart-disease.html.

  • Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A et al (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19:6064–6093

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vannini F, Kashfi K, Nath N (2015) The dual role of iNOS in cancer. Redox Biol 6:334–343

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • von Hagens C, Walter-Sack I, Goeckenjan M et al (2017) Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2). Breast Cancer Res Treat 164:359–369

    Article  CAS  Google Scholar 

  • Wahab A, Gao K, Jia C et al (2017) Significance of resveratrol in clinical management of chronic diseases. Molecules 22:1329

    Article  PubMed Central  CAS  Google Scholar 

  • Walle T, Hsieh F, DeLegge MH et al (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377–1382

    Article  CAS  PubMed  Google Scholar 

  • Yang CS, Wang H (2016) Cancer preventive activities of tea catechins. Molecules 21:1679

    Article  PubMed Central  CAS  Google Scholar 

  • Yao R, Wang Y, Lemon WJ et al (2004) Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions. Oncogene 23:7746–7752

    Article  CAS  PubMed  Google Scholar 

  • Yuan J-M, Stepanov I, Murphy SE et al (2016) Clinical trial of 2-phenethyl isothiocyanate as an inhibitor of metabolic activation of a tobacco-specific lung carcinogen in cigarette smokers. Cancer Prev Res 9:396–405

    Article  CAS  Google Scholar 

  • Zhang D, Qiu L, Jin X et al (2009) Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo. Mol Cancer Res 7:1139–1149

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland

    Aymeric Monteillier & Muriel Cuendet

Authors
  1. Aymeric Monteillier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Muriel Cuendet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muriel Cuendet .

Editor information

Editors and Affiliations

  1. Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA

    John M. Pezzuto

  2. Department of Science, Systems & Models, Roskilde University, Roskilde, Denmark

    Ole Vang

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Monteillier, A., Cuendet, M. (2020). The Use of Anti-Inflammatory Agents for Cancer Chemoprevention. In: Pezzuto, J., Vang, O. (eds) Natural Products for Cancer Chemoprevention. Springer, Cham. https://doi.org/10.1007/978-3-030-39855-2_17

Download citation

Publish with us

Policies and ethics

Search

Navigation